GSK taps Veeva for eClinical tech; Horizon joins U.K. manufacturing brain trust;

> GlaxoSmithKline ($GSK) selected Veeva to handle its CRM services. News

> Horizon Discovery has joined a group of U.K. companies working to improve biologics manufacturing in the country, in line for as much as £652,000 ($971,590) in grant funds. News

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.